img

Global Antifungal infection Therapeutics Market Insights, Forecast to 2034

Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical

Publisher : MRA | Format : PDF

Global Antifungal infection Therapeutics Market Insights, Forecast to 2034

Antifungal drugs are used to treat infections caused by fungus and to prevent the development of fungal infections in patients with weakened immune systems.
Market Analysis and InsightsGlobal Antifungal infection Therapeutics Market
Global Antifungal infection Therapeutics market is expected to reach to US$ 19890 million in 2023, with a positive growth of %, compared with US$ 18650 million in 2022. Backed with the increasing demand from downstream industries, Antifungal infection Therapeutics industry is evaluated to reach US$ 29440 million in 2033. The CAGR will be 6.8% during 2023 to 2033.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Covers
This report presents an overview of global Antifungal infection Therapeutics market from 2018 to 2033, aiming to help readers to get a comprehensive understanding of global Antifungal infection Therapeutics market with multiple angles. Items like regional revenue from 2018 to 2033 and companies’ revenue and gross margin from 2018 to 2023 are analyzed. In addition, revenue of product type and application in each region from 2018 to 2033 are also highlighted.
Companies, Type, Application and Regions Listed in the Report



By Company


Scynexis
Sanofi-Aventis
Pfizer
Novartis
Merck & Co
Kramer Laboratories
Johnson & Johnson
ID Sigma-Aldrich Corporation
Glenmark Pharmaceuticals
Glaxosmithkline
Enzon Pharmaceuticals
Bayer Healthcare
Astellas Pharma
Asperqillus
Alternaria
Abbott Laboratories
Segment by Type
Polyenes
Echinocandins
Azoles
Allylamines
Other Drug types

Segment by Application


Hospitals and Clinics
Dermatology Clinic
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries

Chapter Outline


Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue analysis from 2018 to 2033
Chapter 3Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4Product revenue analysis by type from 2018 to 2033 globally
Chapter 5Product revenue analysis by application from 2018 to 2033 globally
Chapter 6Product revenue analysis by type and application from 2018 to 2033 in US & Canada. Product revenue analysis of each country in US & Canada from 2018 to 2033
Chapter 7Product revenue analysis by type and application from 2018 to 2033 in Europe. Product revenue analysis of each country in Europe from 2018 to 2033
Chapter 8Product revenue analysis by type and application from 2018 to 2033 in China. Product revenue analysis of China from 2018 to 2033
Chapter 9Product revenue analysis by type and application from 2018 to 2033 in Asia (excluding China). Product revenue analysis of each country in Asia (excluding China) from 2018 to 2033
Chapter 10Product revenue analysis by type and application from 2018 to 2033 in Middle East, Africa and Latin America. Product revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2033.
Chapter 11Companies’ outline, covering company’s basic information, major business, Antifungal infection Therapeutics introduction, etc. Antifungal infection Therapeutics Revenue and Gross Margin of each company from 2018 to 2023
Chapter 12MRAResearch’s Conclusions of Antifungal infection Therapeutics
Chapter 13Methodology and Data Sources adopted by MRAResearch

Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Antifungal infection Therapeutics Market Size Growth Rate by Type, 2018 VS 2022 VS 2033
1.2.2 Polyenes
1.2.3 Echinocandins
1.2.4 Azoles
1.2.5 Allylamines
1.2.6 Other Drug types
1.3 Market by Application
1.3.1 Global Antifungal infection Therapeutics Market Size Growth Rate by Application, 2018 VS 2022 VS 2033
1.3.2 Hospitals and Clinics
1.3.3 Dermatology Clinic
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Antifungal infection Therapeutics Market Perspective (2018-2033)
2.2 Global Antifungal infection Therapeutics Growth Trends by Region
2.2.1 Antifungal infection Therapeutics Market Size by Region: 2018 VS 2022 VS 2033
2.2.2 Antifungal infection Therapeutics Historic Market Size by Region (2018-2023)
2.2.3 Antifungal infection Therapeutics Forecasted Market Size by Region (2024-2033)
2.3 Antifungal infection Therapeutics Market Dynamics
2.3.1 Antifungal infection Therapeutics Industry Trends
2.3.2 Antifungal infection Therapeutics Market Drivers
2.3.3 Antifungal infection Therapeutics Market Challenges
2.3.4 Antifungal infection Therapeutics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Antifungal infection Therapeutics by Players
3.1.1 Global Antifungal infection Therapeutics Revenue by Players (2018-2023)
3.1.2 Global Antifungal infection Therapeutics Revenue Market Share by Players (2018-2023)
3.2 Global Antifungal infection Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Antifungal infection Therapeutics, Ranking by Revenue, 2021 VS 2022 VS 2023
3.4 Global Antifungal infection Therapeutics Market Concentration Ratio
3.4.1 Global Antifungal infection Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Antifungal infection Therapeutics Revenue in 2022
3.5 Global Key Players of Antifungal infection Therapeutics Head office and Area Served
3.6 Global Key Players of Antifungal infection Therapeutics, Product and Application
3.7 Global Key Players of Antifungal infection Therapeutics, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Antifungal infection Therapeutics Breakdown Data by Type
4.1 Global Antifungal infection Therapeutics Historic Market Size by Type (2018-2023)
4.2 Global Antifungal infection Therapeutics Forecasted Market Size by Type (2024-2033)
5 Antifungal infection Therapeutics Breakdown Data by Application
5.1 Global Antifungal infection Therapeutics Historic Market Size by Application (2018-2023)
5.2 Global Antifungal infection Therapeutics Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America Antifungal infection Therapeutics Market Size (2018-2033)
6.2 North America Antifungal infection Therapeutics Market Size by Type
6.2.1 North America Antifungal infection Therapeutics Market Size by Type (2018-2023)
6.2.2 North America Antifungal infection Therapeutics Market Size by Type (2024-2033)
6.2.3 North America Antifungal infection Therapeutics Market Share by Type (2018-2033)
6.3 North America Antifungal infection Therapeutics Market Size by Application
6.3.1 North America Antifungal infection Therapeutics Market Size by Application (2018-2023)
6.3.2 North America Antifungal infection Therapeutics Market Size by Application (2024-2033)
6.3.3 North America Antifungal infection Therapeutics Market Share by Application (2018-2033)
6.4 North America Antifungal infection Therapeutics Market Size by Country
6.4.1 North America Antifungal infection Therapeutics Market Size by Country: 2018 VS 2022 VS 2033
6.4.2 North America Antifungal infection Therapeutics Market Size by Country (2018-2023)
6.4.3 North America Antifungal infection Therapeutics Market Size by Country (2024-2033)
6.4.4 U.S.
6.4.5 Canada
7 Europe
7.1 Europe Antifungal infection Therapeutics Market Size (2018-2033)
7.2 Europe Antifungal infection Therapeutics Market Size by Type
7.2.1 Europe Antifungal infection Therapeutics Market Size by Type (2018-2023)
7.2.2 Europe Antifungal infection Therapeutics Market Size by Type (2024-2033)
7.2.3 Europe Antifungal infection Therapeutics Market Share by Type (2018-2033)
7.3 Europe Antifungal infection Therapeutics Market Size by Application
7.3.1 Europe Antifungal infection Therapeutics Market Size by Application (2018-2023)
7.3.2 Europe Antifungal infection Therapeutics Market Size by Application (2024-2033)
7.3.3 Europe Antifungal infection Therapeutics Market Share by Application (2018-2033)
7.4 Europe Antifungal infection Therapeutics Market Size by Country
7.4.1 Europe Antifungal infection Therapeutics Market Size by Country: 2018 VS 2022 VS 2033
7.4.2 Europe Antifungal infection Therapeutics Market Size by Country (2018-2023)
7.4.3 Europe Antifungal infection Therapeutics Market Size by Country (2024-2033)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Antifungal infection Therapeutics Market Size (2018-2033)
8.2 China Antifungal infection Therapeutics Market Size by Type
8.2.1 China Antifungal infection Therapeutics Market Size by Type (2018-2023)
8.2.2 China Antifungal infection Therapeutics Market Size by Type (2024-2033)
8.2.3 China Antifungal infection Therapeutics Market Share by Type (2018-2033)
8.3 China Antifungal infection Therapeutics Market Size by Application
8.3.1 China Antifungal infection Therapeutics Market Size by Application (2018-2023)
8.3.2 China Antifungal infection Therapeutics Market Size by Application (2024-2033)
8.3.3 China Antifungal infection Therapeutics Market Share by Application (2018-2033)
9 Asia (excluding China)
9.1 Asia Antifungal infection Therapeutics Market Size (2018-2033)
9.2 Asia Antifungal infection Therapeutics Market Size by Type
9.2.1 Asia Antifungal infection Therapeutics Market Size by Type (2018-2023)
9.2.2 Asia Antifungal infection Therapeutics Market Size by Type (2024-2033)
9.2.3 Asia Antifungal infection Therapeutics Market Share by Type (2018-2033)
9.3 Asia Antifungal infection Therapeutics Market Size by Application
9.3.1 Asia Antifungal infection Therapeutics Market Size by Application (2018-2023)
9.3.2 Asia Antifungal infection Therapeutics Market Size by Application (2024-2033)
9.3.3 Asia Antifungal infection Therapeutics Market Share by Application (2018-2033)
9.4 Asia Antifungal infection Therapeutics Market Size by Region
9.4.1 Asia Antifungal infection Therapeutics Market Size by Region: 2018 VS 2022 VS 2033
9.4.2 Asia Antifungal infection Therapeutics Market Size by Region (2018-2023)
9.4.3 Asia Antifungal infection Therapeutics Market Size by Region (2024-2033)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Antifungal infection Therapeutics Market Size (2018-2033)
10.2 Middle East, Africa, and Latin America Antifungal infection Therapeutics Market Size by Type
10.2.1 Middle East, Africa, and Latin America Antifungal infection Therapeutics Market Size by Type (2018-2023)
10.2.2 Middle East, Africa, and Latin America Antifungal infection Therapeutics Market Size by Type (2024-2033)
10.2.3 Middle East, Africa, and Latin America Antifungal infection Therapeutics Market Share by Type (2018-2033)
10.3 Middle East, Africa, and Latin America Antifungal infection Therapeutics Market Size by Application
10.3.1 Middle East, Africa, and Latin America Antifungal infection Therapeutics Market Size by Application (2018-2023)
10.3.2 Middle East, Africa, and Latin America Antifungal infection Therapeutics Market Size by Application (2024-2033)
10.3.3 Middle East, Africa, and Latin America Antifungal infection Therapeutics Market Share by Application (2018-2033)
10.4 Middle East, Africa, and Latin America Antifungal infection Therapeutics Market Size by Country
10.4.1 Middle East, Africa, and Latin America Antifungal infection Therapeutics Market Size by Country: 2018 VS 2022 VS 2033
10.4.2 Middle East, Africa, and Latin America Antifungal infection Therapeutics Market Size by Country (2018-2023)
10.4.3 Middle East, Africa, and Latin America Antifungal infection Therapeutics Market Size by Country (2024-2033)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Scynexis
11.1.1 Scynexis Company Details
11.1.2 Scynexis Business Overview
11.1.3 Scynexis Antifungal infection Therapeutics Introduction
11.1.4 Scynexis Revenue in Antifungal infection Therapeutics Business (2018-2023)
11.1.5 Scynexis Recent Developments
11.2 Sanofi-Aventis
11.2.1 Sanofi-Aventis Company Details
11.2.2 Sanofi-Aventis Business Overview
11.2.3 Sanofi-Aventis Antifungal infection Therapeutics Introduction
11.2.4 Sanofi-Aventis Revenue in Antifungal infection Therapeutics Business (2018-2023)
11.2.5 Sanofi-Aventis Recent Developments
11.3 Pfizer
11.3.1 Pfizer Company Details
11.3.2 Pfizer Business Overview
11.3.3 Pfizer Antifungal infection Therapeutics Introduction
11.3.4 Pfizer Revenue in Antifungal infection Therapeutics Business (2018-2023)
11.3.5 Pfizer Recent Developments
11.4 Novartis
11.4.1 Novartis Company Details
11.4.2 Novartis Business Overview
11.4.3 Novartis Antifungal infection Therapeutics Introduction
11.4.4 Novartis Revenue in Antifungal infection Therapeutics Business (2018-2023)
11.4.5 Novartis Recent Developments
11.5 Merck & Co
11.5.1 Merck & Co Company Details
11.5.2 Merck & Co Business Overview
11.5.3 Merck & Co Antifungal infection Therapeutics Introduction
11.5.4 Merck & Co Revenue in Antifungal infection Therapeutics Business (2018-2023)
11.5.5 Merck & Co Recent Developments
11.6 Kramer Laboratories
11.6.1 Kramer Laboratories Company Details
11.6.2 Kramer Laboratories Business Overview
11.6.3 Kramer Laboratories Antifungal infection Therapeutics Introduction
11.6.4 Kramer Laboratories Revenue in Antifungal infection Therapeutics Business (2018-2023)
11.6.5 Kramer Laboratories Recent Developments
11.7 Johnson & Johnson
11.7.1 Johnson & Johnson Company Details
11.7.2 Johnson & Johnson Business Overview
11.7.3 Johnson & Johnson Antifungal infection Therapeutics Introduction
11.7.4 Johnson & Johnson Revenue in Antifungal infection Therapeutics Business (2018-2023)
11.7.5 Johnson & Johnson Recent Developments
11.8 ID Sigma-Aldrich Corporation
11.8.1 ID Sigma-Aldrich Corporation Company Details
11.8.2 ID Sigma-Aldrich Corporation Business Overview
11.8.3 ID Sigma-Aldrich Corporation Antifungal infection Therapeutics Introduction
11.8.4 ID Sigma-Aldrich Corporation Revenue in Antifungal infection Therapeutics Business (2018-2023)
11.8.5 ID Sigma-Aldrich Corporation Recent Developments
11.9 Glenmark Pharmaceuticals
11.9.1 Glenmark Pharmaceuticals Company Details
11.9.2 Glenmark Pharmaceuticals Business Overview
11.9.3 Glenmark Pharmaceuticals Antifungal infection Therapeutics Introduction
11.9.4 Glenmark Pharmaceuticals Revenue in Antifungal infection Therapeutics Business (2018-2023)
11.9.5 Glenmark Pharmaceuticals Recent Developments
11.10 Glaxosmithkline
11.10.1 Glaxosmithkline Company Details
11.10.2 Glaxosmithkline Business Overview
11.10.3 Glaxosmithkline Antifungal infection Therapeutics Introduction
11.10.4 Glaxosmithkline Revenue in Antifungal infection Therapeutics Business (2018-2023)
11.10.5 Glaxosmithkline Recent Developments
11.11 Enzon Pharmaceuticals
11.11.1 Enzon Pharmaceuticals Company Details
11.11.2 Enzon Pharmaceuticals Business Overview
11.11.3 Enzon Pharmaceuticals Antifungal infection Therapeutics Introduction
11.11.4 Enzon Pharmaceuticals Revenue in Antifungal infection Therapeutics Business (2018-2023)
11.11.5 Enzon Pharmaceuticals Recent Developments
11.12 Bayer Healthcare
11.12.1 Bayer Healthcare Company Details
11.12.2 Bayer Healthcare Business Overview
11.12.3 Bayer Healthcare Antifungal infection Therapeutics Introduction
11.12.4 Bayer Healthcare Revenue in Antifungal infection Therapeutics Business (2018-2023)
11.12.5 Bayer Healthcare Recent Developments
11.13 Astellas Pharma
11.13.1 Astellas Pharma Company Details
11.13.2 Astellas Pharma Business Overview
11.13.3 Astellas Pharma Antifungal infection Therapeutics Introduction
11.13.4 Astellas Pharma Revenue in Antifungal infection Therapeutics Business (2018-2023)
11.13.5 Astellas Pharma Recent Developments
11.14 Asperqillus
11.14.1 Asperqillus Company Details
11.14.2 Asperqillus Business Overview
11.14.3 Asperqillus Antifungal infection Therapeutics Introduction
11.14.4 Asperqillus Revenue in Antifungal infection Therapeutics Business (2018-2023)
11.14.5 Asperqillus Recent Developments
11.15 Alternaria
11.15.1 Alternaria Company Details
11.15.2 Alternaria Business Overview
11.15.3 Alternaria Antifungal infection Therapeutics Introduction
11.15.4 Alternaria Revenue in Antifungal infection Therapeutics Business (2018-2023)
11.15.5 Alternaria Recent Developments
11.16 Abbott Laboratories
11.16.1 Abbott Laboratories Company Details
11.16.2 Abbott Laboratories Business Overview
11.16.3 Abbott Laboratories Antifungal infection Therapeutics Introduction
11.16.4 Abbott Laboratories Revenue in Antifungal infection Therapeutics Business (2018-2023)
11.16.5 Abbott Laboratories Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Antifungal infection Therapeutics Market Size Growth Rate by Type (US$ Million), 2018 VS 2022 VS 2033
Table 2. Key Players of Polyenes
Table 3. Key Players of Echinocandins
Table 4. Key Players of Azoles
Table 5. Key Players of Allylamines
Table 6. Key Players of Other Drug types
Table 7. Global Antifungal infection Therapeutics Market Size Growth Rate by Application (US$ Million), 2018 VS 2022 VS 2033
Table 8. Global Antifungal infection Therapeutics Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2033
Table 9. Global Antifungal infection Therapeutics Market Size by Region (2018-2023) & (US$ Million)
Table 10. Global Antifungal infection Therapeutics Market Share by Region (2018-2023)
Table 11. Global Antifungal infection Therapeutics Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 12. Global Antifungal infection Therapeutics Market Share by Region (2024-2033)
Table 13. Antifungal infection Therapeutics Market Trends
Table 14. Antifungal infection Therapeutics Market Drivers
Table 15. Antifungal infection Therapeutics Market Challenges
Table 16. Antifungal infection Therapeutics Market Restraints
Table 17. Global Antifungal infection Therapeutics Revenue by Players (2018-2023) & (US$ Million)
Table 18. Global Antifungal infection Therapeutics Revenue Share by Players (2018-2023)
Table 19. Global Top Antifungal infection Therapeutics by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Antifungal infection Therapeutics as of 2022)
Table 20. Global Antifungal infection Therapeutics Industry Ranking 2021 VS 2022 VS 2023
Table 21. Global 5 Largest Players Market Share by Antifungal infection Therapeutics Revenue (CR5 and HHI) & (2018-2023)
Table 22. Global Key Players of Antifungal infection Therapeutics, Headquarters and Area Served
Table 23. Global Key Players of Antifungal infection Therapeutics, Product and Application
Table 24. Global Key Players of Antifungal infection Therapeutics, Product and Application
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Antifungal infection Therapeutics Market Size by Type (2018-2023) & (US$ Million)
Table 27. Global Antifungal infection Therapeutics Revenue Market Share by Type (2018-2023)
Table 28. Global Antifungal infection Therapeutics Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 29. Global Antifungal infection Therapeutics Revenue Market Share by Type (2024-2033)
Table 30. Global Antifungal infection Therapeutics Market Size by Application (2018-2023) & (US$ Million)
Table 31. Global Antifungal infection Therapeutics Revenue Share by Application (2018-2023)
Table 32. Global Antifungal infection Therapeutics Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 33. Global Antifungal infection Therapeutics Revenue Share by Application (2024-2033)
Table 34. North America Antifungal infection Therapeutics Market Size by Type (2018-2023) & (US$ Million)
Table 35. North America Antifungal infection Therapeutics Market Size by Type (2024-2033) & (US$ Million)
Table 36. North America Antifungal infection Therapeutics Market Size by Application (2018-2023) & (US$ Million)
Table 37. North America Antifungal infection Therapeutics Market Size by Application (2024-2033) & (US$ Million)
Table 38. North America Antifungal infection Therapeutics Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2033
Table 39. North America Antifungal infection Therapeutics Market Size by Country (2018-2023) & (US$ Million)
Table 40. North America Antifungal infection Therapeutics Market Size by Country (2024-2033) & (US$ Million)
Table 41. Europe Antifungal infection Therapeutics Market Size by Type (2018-2023) & (US$ Million)
Table 42. Europe Antifungal infection Therapeutics Market Size by Type (2024-2033) & (US$ Million)
Table 43. Europe Antifungal infection Therapeutics Market Size by Application (2018-2023) & (US$ Million)
Table 44. Europe Antifungal infection Therapeutics Market Size by Application (2024-2033) & (US$ Million)
Table 45. Europe Antifungal infection Therapeutics Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2033
Table 46. Europe Antifungal infection Therapeutics Market Size by Country (2018-2023) & (US$ Million)
Table 47. Europe Antifungal infection Therapeutics Market Size by Country (2024-2033) & (US$ Million)
Table 48. China Antifungal infection Therapeutics Market Size by Type (2018-2023) & (US$ Million)
Table 49. China Antifungal infection Therapeutics Market Size by Type (2024-2033) & (US$ Million)
Table 50. China Antifungal infection Therapeutics Market Size by Application (2018-2023) & (US$ Million)
Table 51. China Antifungal infection Therapeutics Market Size by Application (2024-2033) & (US$ Million)
Table 52. Asia Antifungal infection Therapeutics Market Size by Type (2018-2023) & (US$ Million)
Table 53. Asia Antifungal infection Therapeutics Market Size by Type (2024-2033) & (US$ Million)
Table 54. Asia Antifungal infection Therapeutics Market Size by Application (2018-2023) & (US$ Million)
Table 55. Asia Antifungal infection Therapeutics Market Size by Application (2024-2033) & (US$ Million)
Table 56. Asia Antifungal infection Therapeutics Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2033
Table 57. Asia Antifungal infection Therapeutics Market Size by Region (2018-2023) & (US$ Million)
Table 58. Asia Antifungal infection Therapeutics Market Size by Region (2024-2033) & (US$ Million)
Table 59. Middle East, Africa, and Latin America Antifungal infection Therapeutics Market Size by Type (2018-2023) & (US$ Million)
Table 60. Middle East, Africa, and Latin America Antifungal infection Therapeutics Market Size by Type (2024-2033) & (US$ Million)
Table 61. Middle East, Africa, and Latin America Antifungal infection Therapeutics Market Size by Application (2018-2023) & (US$ Million)
Table 62. Middle East, Africa, and Latin America Antifungal infection Therapeutics Market Size by Application (2024-2033) & (US$ Million)
Table 63. Middle East, Africa, and Latin America Antifungal infection Therapeutics Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2033
Table 64. Middle East, Africa, and Latin America Antifungal infection Therapeutics Market Size by Country (2018-2023) & (US$ Million)
Table 65. Middle East, Africa, and Latin America Antifungal infection Therapeutics Market Size by Country (2024-2033) & (US$ Million)
Table 66. Scynexis Company Details
Table 67. Scynexis Business Overview
Table 68. Scynexis Antifungal infection Therapeutics Product
Table 69. Scynexis Revenue in Antifungal infection Therapeutics Business (2018-2023) & (US$ Million)
Table 70. Scynexis Recent Developments
Table 71. Sanofi-Aventis Company Details
Table 72. Sanofi-Aventis Business Overview
Table 73. Sanofi-Aventis Antifungal infection Therapeutics Product
Table 74. Sanofi-Aventis Revenue in Antifungal infection Therapeutics Business (2018-2023) & (US$ Million)
Table 75. Sanofi-Aventis Recent Developments
Table 76. Pfizer Company Details
Table 77. Pfizer Business Overview
Table 78. Pfizer Antifungal infection Therapeutics Product
Table 79. Pfizer Revenue in Antifungal infection Therapeutics Business (2018-2023) & (US$ Million)
Table 80. Pfizer Recent Developments
Table 81. Novartis Company Details
Table 82. Novartis Business Overview
Table 83. Novartis Antifungal infection Therapeutics Product
Table 84. Novartis Revenue in Antifungal infection Therapeutics Business (2018-2023) & (US$ Million)
Table 85. Novartis Recent Developments
Table 86. Merck & Co Company Details
Table 87. Merck & Co Business Overview
Table 88. Merck & Co Antifungal infection Therapeutics Product
Table 89. Merck & Co Revenue in Antifungal infection Therapeutics Business (2018-2023) & (US$ Million)
Table 90. Merck & Co Recent Developments
Table 91. Kramer Laboratories Company Details
Table 92. Kramer Laboratories Business Overview
Table 93. Kramer Laboratories Antifungal infection Therapeutics Product
Table 94. Kramer Laboratories Revenue in Antifungal infection Therapeutics Business (2018-2023) & (US$ Million)
Table 95. Kramer Laboratories Recent Developments
Table 96. Johnson & Johnson Company Details
Table 97. Johnson & Johnson Business Overview
Table 98. Johnson & Johnson Antifungal infection Therapeutics Product
Table 99. Johnson & Johnson Revenue in Antifungal infection Therapeutics Business (2018-2023) & (US$ Million)
Table 100. Johnson & Johnson Recent Developments
Table 101. ID Sigma-Aldrich Corporation Company Details
Table 102. ID Sigma-Aldrich Corporation Business Overview
Table 103. ID Sigma-Aldrich Corporation Antifungal infection Therapeutics Product
Table 104. ID Sigma-Aldrich Corporation Revenue in Antifungal infection Therapeutics Business (2018-2023) & (US$ Million)
Table 105. ID Sigma-Aldrich Corporation Recent Developments
Table 106. Glenmark Pharmaceuticals Company Details
Table 107. Glenmark Pharmaceuticals Business Overview
Table 108. Glenmark Pharmaceuticals Antifungal infection Therapeutics Product
Table 109. Glenmark Pharmaceuticals Revenue in Antifungal infection Therapeutics Business (2018-2023) & (US$ Million)
Table 110. Glenmark Pharmaceuticals Recent Developments
Table 111. Glaxosmithkline Company Details
Table 112. Glaxosmithkline Business Overview
Table 113. Glaxosmithkline Antifungal infection Therapeutics Product
Table 114. Glaxosmithkline Revenue in Antifungal infection Therapeutics Business (2018-2023) & (US$ Million)
Table 115. Glaxosmithkline Recent Developments
Table 116. Enzon Pharmaceuticals Company Details
Table 117. Enzon Pharmaceuticals Business Overview
Table 118. Enzon Pharmaceuticals Antifungal infection Therapeutics Product
Table 119. Enzon Pharmaceuticals Revenue in Antifungal infection Therapeutics Business (2018-2023) & (US$ Million)
Table 120. Enzon Pharmaceuticals Recent Developments
Table 121. Bayer Healthcare Company Details
Table 122. Bayer Healthcare Business Overview
Table 123. Bayer Healthcare Antifungal infection Therapeutics Product
Table 124. Bayer Healthcare Revenue in Antifungal infection Therapeutics Business (2018-2023) & (US$ Million)
Table 125. Bayer Healthcare Recent Developments
Table 126. Astellas Pharma Company Details
Table 127. Astellas Pharma Business Overview
Table 128. Astellas Pharma Antifungal infection Therapeutics Product
Table 129. Astellas Pharma Revenue in Antifungal infection Therapeutics Business (2018-2023) & (US$ Million)
Table 130. Astellas Pharma Recent Developments
Table 131. Asperqillus Company Details
Table 132. Asperqillus Business Overview
Table 133. Asperqillus Antifungal infection Therapeutics Product
Table 134. Asperqillus Revenue in Antifungal infection Therapeutics Business (2018-2023) & (US$ Million)
Table 135. Asperqillus Recent Developments
Table 136. Alternaria Company Details
Table 137. Alternaria Business Overview
Table 138. Alternaria Antifungal infection Therapeutics Product
Table 139. Alternaria Revenue in Antifungal infection Therapeutics Business (2018-2023) & (US$ Million)
Table 140. Alternaria Recent Developments
Table 141. Abbott Laboratories Company Details
Table 142. Abbott Laboratories Business Overview
Table 143. Abbott Laboratories Antifungal infection Therapeutics Product
Table 144. Abbott Laboratories Revenue in Antifungal infection Therapeutics Business (2018-2023) & (US$ Million)
Table 145. Abbott Laboratories Recent Developments
Table 146. Research Programs/Design for This Report
Table 147. Key Data Information from Secondary Sources
Table 148. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Antifungal infection Therapeutics Market Size Growth Rate by Type, 2018 VS 2022 VS 2033 (US$ Million)
Figure 2. Global Antifungal infection Therapeutics Market Share by Type: 2022 VS 2033
Figure 3. Polyenes Features
Figure 4. Echinocandins Features
Figure 5. Azoles Features
Figure 6. Allylamines Features
Figure 7. Other Drug types Features
Figure 8. Global Antifungal infection Therapeutics Market Size Growth Rate by Application, 2018 VS 2022 VS 2033 (US$ Million)
Figure 9. Global Antifungal infection Therapeutics Market Share by Application: 2022 VS 2033
Figure 10. Hospitals and Clinics Case Studies
Figure 11. Dermatology Clinic Case Studies
Figure 12. Antifungal infection Therapeutics Report Years Considered
Figure 13. Global Antifungal infection Therapeutics Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 14. Global Antifungal infection Therapeutics Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 15. Global Antifungal infection Therapeutics Market Share by Region: 2022 VS 2033
Figure 16. Global Antifungal infection Therapeutics Market Share by Players in 2022
Figure 17. Global Top Antifungal infection Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Antifungal infection Therapeutics as of 2022)
Figure 18. The Top 10 and 5 Players Market Share by Antifungal infection Therapeutics Revenue in 2022
Figure 19. North America Antifungal infection Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 20. North America Antifungal infection Therapeutics Market Share by Type (2018-2033)
Figure 21. North America Antifungal infection Therapeutics Market Share by Application (2018-2033)
Figure 22. North America Antifungal infection Therapeutics Market Share by Country (2018-2033)
Figure 23. United States Antifungal infection Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 24. Canada Antifungal infection Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 25. Europe Antifungal infection Therapeutics Market Size YoY (2018-2033) & (US$ Million)
Figure 26. Europe Antifungal infection Therapeutics Market Share by Type (2018-2033)
Figure 27. Europe Antifungal infection Therapeutics Market Share by Application (2018-2033)
Figure 28. Europe Antifungal infection Therapeutics Market Share by Country (2018-2033)
Figure 29. Germany Antifungal infection Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 30. France Antifungal infection Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 31. U.K. Antifungal infection Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 32. Italy Antifungal infection Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 33. Russia Antifungal infection Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 34. Nordic Countries Antifungal infection Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 35. China Antifungal infection Therapeutics Market Size YoY (2018-2033) & (US$ Million)
Figure 36. China Antifungal infection Therapeutics Market Share by Type (2018-2033)
Figure 37. China Antifungal infection Therapeutics Market Share by Application (2018-2033)
Figure 38. Asia Antifungal infection Therapeutics Market Size YoY (2018-2033) & (US$ Million)
Figure 39. Asia Antifungal infection Therapeutics Market Share by Type (2018-2033)
Figure 40. Asia Antifungal infection Therapeutics Market Share by Application (2018-2033)
Figure 41. Asia Antifungal infection Therapeutics Market Share by Region (2018-2033)
Figure 42. Japan Antifungal infection Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 43. South Korea Antifungal infection Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 44. China Taiwan Antifungal infection Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 45. Southeast Asia Antifungal infection Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 46. India Antifungal infection Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 47. Australia Antifungal infection Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 48. Middle East, Africa, and Latin America Antifungal infection Therapeutics Market Size YoY (2018-2033) & (US$ Million)
Figure 49. Middle East, Africa, and Latin America Antifungal infection Therapeutics Market Share by Type (2018-2033)
Figure 50. Middle East, Africa, and Latin America Antifungal infection Therapeutics Market Share by Application (2018-2033)
Figure 51. Middle East, Africa, and Latin America Antifungal infection Therapeutics Market Share by Country (2018-2033)
Figure 52. Brazil Antifungal infection Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 53. Mexico Antifungal infection Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 54. Turkey Antifungal infection Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 55. Saudi Arabia Antifungal infection Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 56. Israel Antifungal infection Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 57. GCC Countries Antifungal infection Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 58. Scynexis Revenue Growth Rate in Antifungal infection Therapeutics Business (2018-2023)
Figure 59. Sanofi-Aventis Revenue Growth Rate in Antifungal infection Therapeutics Business (2018-2023)
Figure 60. Pfizer Revenue Growth Rate in Antifungal infection Therapeutics Business (2018-2023)
Figure 61. Novartis Revenue Growth Rate in Antifungal infection Therapeutics Business (2018-2023)
Figure 62. Merck & Co Revenue Growth Rate in Antifungal infection Therapeutics Business (2018-2023)
Figure 63. Kramer Laboratories Revenue Growth Rate in Antifungal infection Therapeutics Business (2018-2023)
Figure 64. Johnson & Johnson Revenue Growth Rate in Antifungal infection Therapeutics Business (2018-2023)
Figure 65. ID Sigma-Aldrich Corporation Revenue Growth Rate in Antifungal infection Therapeutics Business (2018-2023)
Figure 66. Glenmark Pharmaceuticals Revenue Growth Rate in Antifungal infection Therapeutics Business (2018-2023)
Figure 67. Glaxosmithkline Revenue Growth Rate in Antifungal infection Therapeutics Business (2018-2023)
Figure 68. Enzon Pharmaceuticals Revenue Growth Rate in Antifungal infection Therapeutics Business (2018-2023)
Figure 69. Bayer Healthcare Revenue Growth Rate in Antifungal infection Therapeutics Business (2018-2023)
Figure 70. Astellas Pharma Revenue Growth Rate in Antifungal infection Therapeutics Business (2018-2023)
Figure 71. Asperqillus Revenue Growth Rate in Antifungal infection Therapeutics Business (2018-2023)
Figure 72. Alternaria Revenue Growth Rate in Antifungal infection Therapeutics Business (2018-2023)
Figure 73. Abbott Laboratories Revenue Growth Rate in Antifungal infection Therapeutics Business (2018-2023)
Figure 74. Bottom-up and Top-down Approaches for This Report
Figure 75. Data Triangulation
Figure 76. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries